SGN-CD19A

TrialTitleStudy Record DetailPhaseSponsor/Colaborator
SGN19A-001A Safety Study of SGN-CD19A for B-Cell LymphomaNCT01786135Phase ISeattle Genetics, Inc.
SGN19A-002A Safety Study of SGN-CD19A for Leukemia and LymphomaNCT01786096Phase ISeattle Genetics, Inc.

Last Editorial Review: February 13, 2015